News

• CMP Pharma’s Potassium Phosphates Injection Receives FDA Shelf Life Extension for Specific Lots

• CMP Pharma, Inc. Announces Unit Dose Packaging for CaroSpir^®, The First and Only FDA-Approved Spironolactone Oral Suspension

• First FDA approved Potassium Phosphates Injection from CMP Pharma Is Now Available

• First FDA approved Potassium Phosphates Injection from CMP Pharma Has Been Approved

• CMP Pharma, Inc Announces That CaroSpir^®, The First And Only FDA-Approved Spironolactone Oral Suspension, Is Now Available

• CMP Pharma, Inc. Announces FDA Approval of CaroSpir^® (Spironolactone Oral Suspension, 25 mg/5 mL)

• CMP Pharma and Generic Specialty Pharma Sign Product Development Agreement

• TRIANEX^® 0.05%(Triamcinolone Acetonide Ointment,USP) Now Available from Promius Pharma^®, LLC

• Carolina Medical Products Now CMP Pharma

• CMP Pharma and Kiel Laboratories Sign Development Agreement for Two NDA Products